Avoid Errors With Wegovy During Transitions of Care

August 2021

You'll see patients admitted on the new weekly injectable semaglutide (Wegovy) for weight loss.

It's the same GLP-1 agonist as weekly injectable Ozempic or daily oral Rybelsus for type 2 diabetes.

Using Wegovy 2.4 mg weekly for about a year leads to roughly 10% to 12% more weight loss than with placebo, or 20 lb for a 200 lb patient.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote